China Universal Asset Management Company’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $482K | Buy |
15,412
+59
| +0.4% | +$1.85K | 0.05% | 243 |
|
|
2025
Q1 | $515K | Sell |
15,353
-813
| -5% | -$27.3K | 0.05% | 246 |
|
|
2024
Q4 | $634K | Buy |
16,166
+1,594
| +11% | +$62.5K | 0.06% | 217 |
|
|
2024
Q3 | $574K | Buy |
14,572
+5,704
| +64% | +$225K | 0.06% | 202 |
|
|
2024
Q2 | $346K | Sell |
8,868
-5,652
| -39% | -$220K | 0.05% | 177 |
|
|
2024
Q1 | $625K | Buy |
14,520
+5,974
| +70% | +$257K | 0.08% | 167 |
|
|
2023
Q4 | $394K | Buy |
8,546
+6,895
| +418% | +$318K | 0.08% | 158 |
|
|
2023
Q3 | $56.4K | Buy |
1,651
+818
| +98% | +$27.9K | 0.02% | 227 |
|
|
2023
Q2 | $32.1K | Sell |
833
-15
| -2% | -$578 | 0.01% | 234 |
|
|
2023
Q1 | $30.4K | Buy |
848
+213
| +34% | +$7.62K | 0.01% | 184 |
|
|
2022
Q4 | $25K | Buy |
635
+52
| +9% | +$2.05K | 0.01% | 164 |
|
|
2022
Q3 | $21K | Buy |
+583
| New | +$21K | 0.01% | 155 |
|